CDKN2A and prostate intraepithelial neoplasia: We observed the development of mouse prostatic intraepithelial neoplasia in p16L/L:PB-Cre4 mice at eight months of age, providing the first line of evidence demonstrating that p16Ink4a deletion can initiate oncogenic transformation and PIN formation in the mouse prostate.